N-butyldeoxynojirimycin (miglustat) ameliorates pulmonary fibrosis through inhibition of nuclear translocation of Smad2/3
Nakamura, Hiroyuki, Zhou, Yuan, Sakamoto, Yuka, Yamazaki, Ayako, Kurumiya, Eon, Yamazaki, Risa, Hayashi, Kyota, Kasuya, Yoshitoshi, Watanabe, Kazuaki, Kasahara, Junya, Takabatake, Mamoru, Tatsumi, Koichiro, Yoshino, Ichiro, Honda, Takuya, Murayama, Toshihiko
Published in Biomedicine & pharmacotherapy (01.04.2023)
Published in Biomedicine & pharmacotherapy (01.04.2023)
Get full text
Journal Article
Eliglustat exerts anti-fibrotic effects by activating SREBP2 in TGF-β1-treated myofibroblasts derived from patients with idiopathic pulmonary fibrosis
Kurumiya, Eon, Iwata, Mayuu, Kasuya, Yoshitoshi, Tatsumi, Koichiro, Honda, Takuya, Murayama, Toshihiko, Nakamura, Hiroyuki
Published in European journal of pharmacology (05.03.2024)
Published in European journal of pharmacology (05.03.2024)
Get full text
Journal Article